L11% degli adulti li assume oggi per perdere peso e lobesit scende al 36,4%
If your confidence improved on a GLP-1, coming off it can stir up old insecurities or beliefs about your worth and appearance
*Correspondence: Shuchun Chen, [email protected] This article was submitted to Obesity, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
NICE guidance supports the use of GLP-1 receptor agonists for type 2 diabetes (NG28) when certain criteria are met, typically after other treatments have been tried
What Exact Oral-Hygiene Moves Actually Change The Smell
The WHO's December 2025 guidelines define long-term use as continuous treatment for six months or more, often years